A woman who has lost more than three stone while taking Mounjaro has revealed how using the GLP-1 medication has 'ruined' her.

According to Research by SNS Insider, The U.S. GLP-1 Receptor Agonist Market to Reach USD 113.13 Billion by 2032, Driven by Rising Prevalence of Type 2 Diabetes and Demand for Obesity-Related ...

There is a growing trend of restaurants creating special menus of bite-sized entrées that cater to people on GLP-1 ...

The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But GLP-1s can be an effective reinforcement of diet and exercise.

Curious about the viral “Japanese Mounjaro” drink? Learn what it is, what it’s made of, and whether it can actually support ...

A warning has now been issued after ‘GLP-1 weight-loss patches’ were spotted online amidst the surge in Mounjaro popularity.

A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...

“The number one reason patients stop taking Wegovy or Mounjaro is gastrointestinal distress,” says Curran. “The nausea, vomiting, diarrhea, and constipation can be really intense, especially if a dose ...

In the second part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, explains how dual-action metabolic therapies can address clinical or tolerability gaps observed in ...

Indian equities rebounded in Q2 2025 amid rate cuts and capex surge. Explore how Baron India Fund is positioned for growth; ...

The first human-tested weight-loss drug that burns calories through creatine-based heat generation, without reducing appetite, has successfully completed its Phase I trial.

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...